Konduri N, Aboagye-Nyame F, Mabirizi D, Hoppenworth K, Kibria MG, Doumbia S, Williams L, Mazibuko G.Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals. Digit Health. 2018 May 3;4:2055207618771407. doi: 10.1177/2055207618771407. Read the full article
A multicountry user experience analysis of e-TB Manager and an in-depth study in Ukraine were published. However, the procedural aspects of e-TB Manager implementation in each country were not documented. While facilitators and barriers for eHealth implementation in resource-constrained settings are well known, the objective of this paper is to summarize the tailored implementation approaches given local context, which … Read more
Konduri N, Bastos LGV, Sawyer K, Reciolino LFA. User experience analysis of an eHealth system for tuberculosis in resource-constrained settings: A nine-country comparison. International Journal of Medical Informatics 102 2017; 118-29. Read the full article
Konduri N, Rauscher M. Shio-Chu JW, Malpica-Llanos T. Individual capacity-building approaches in a global pharmaceutical systems strengthening program: a selected review. Journal of Pharmaceutical Policy and Practice 2017;10:16. Read the full article
Konduri N, Sawyer K, Nizova N. User experience analysis of e-TB Manager, a nationwide electronic tuberculosis recording and reporting system in Ukraine. European Respiratory Journal Open Research 3;2017: 00002-2017. Read the full article
Konduri N, Delmotte E, Rutta E. Engagement of the private pharmaceutical sector for TB control: Rhetoric or reality? Journal: Journal of Pharmaceutical Policy and Practice, 2017, Volume 10, Number 1 Read the full article
Konduri N, Lebega O. Analysis of medicines expenditure in ukraine: Implications for rational selection. E9 Short oral presentation, Part 2a (Practice & Education) at the 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2016, Buenos Aires, Argentina. August 30, 2016.
Pharmaceuticals may constitute as much as 40% of the health care budget in low and middle-income countries, yet large portions of the population may lack access to even the most essential medicines. The limited public sector funds are frequently spent on ineffective or unnecessary medications. An analysis of past spending patterns on procurement of medicines … Read more